ET-70 COMBINATION OF oHSV WITH INTEGRIN β1 NEUTRALIZING ANTIBODY (OS2966) AUGMENTS oHSV THERAPY

Oncolytic HSV (oHSV) is a biologic therapy currently being tested in patients. We have previously shown that oHSV-induced Cysteine-rich 61 protein (CCN1) binds with integrin α6β1, activating a type 1 IFN-antiviral defense response. oHSV-induced CCN1 induction also increases macrophage infiltration a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yoo, Ji Young, Banasavadi-Siddegowda, Yeshavanth Yeshavanth, Relation, Theresa, Aghi, Manish, Kaur, Balveen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218167/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou255.67
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak